Should I buy Equifax (EFX) stock or is it too late?

Equifax · Industrials · price $149

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: BMO Capital — 74% of its targets hit on this sector (179 calls tested). It aims for $160 (+7.3 %), call made on October 1, 2026, maturing on October 1, 2027 (13 d ago).

The 6 reliable analysts $192+29 %

The 5 other firms $220+48 %

How to read it: the 6 reliable firms are not filtered by optimism — 6 aim above the price, 0 below, hence their $192 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Equifax

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Barclays	65 %	+11.1 %	23	$155 +4%
JP Morgan	58 %	+8.6 %	12	$230 +54%
Baird	54 %	+5.2 %	13	$232 +56%
Stifel	50 %	+3.5 %	10	$235 +58%
Needham	36 %	-0.8 %	22	$190 +27%
B of A Securities	0 %	-8.9 %	6	$225 +51%
Wells Fargo	33 %	-9.1 %	15	$200 +34%
Morgan Stanley	27 %	-9.9 %	11	$205 +38%

In short — Should you invest in Equifax? Is it too late, still worth it? Analysts are overwhelmingly positive (82% buy, median target $205, i.e. +38%), and the most reliable on EFX targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

82% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.
Median price target $205, i.e. +38% from the current price ($149).
The most reliable firm on EFX, Goldman Sachs (75% hit rate, 4 scored calls), targets $208 (call made on February 9, 2026, maturing on February 9, 2027) (+40%) in its most recent call.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 11 ratings, 2 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on EFX

Median target $205 (+38%) · 11 ratings · Buy consensus

Strong Buy00%

Buy982%

Hold218%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Equifax now?

We won't decide for you. The facts: 82% of analysts rate it a buy, median target $205 (+38%), and Goldman Sachs (most reliable on EFX, 75%) targets $208. Weigh that against valuation (P/E ~26). This is not personalized advice.

Is it too late to invest in Equifax?

Not according to analysts: the median target ($205) is still +38% above the current price ($149) (most reliable on EFX: Goldman Sachs, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Equifax still worth investing in?

It depends on the gap between the price ($149) and its estimated value: analysts target $205 on median (+38%), with 82% buys (most reliable on EFX: Goldman Sachs, 75%). Cross-check with their real reliability on EFX and the cautions above. Information, not advice.

What's the main risk in buying EFX?

The consensus is not unanimous: of 11 ratings, 2 are neutral.

→ Go deeper: the full Equifax profile (consensus, analyst reliability, price target, performance).